FDA approved Armodafinil

Lupin has received conditional FDA approval for the drug Armodafinil.

Armodafinil (Nuvigil or Waklert) is selective alpha 1-agonists of primarily centrally acting. There is evidence that it acts through the glutamatergic system and increases the synthesis of glutamic acid by inhibiting the release of GABA. The drug was developed primarily for the treatment of narcolepsy. In 1998 it became the first drug among similar substances that promoted wakefulness and were allowed in the United States.

By clinical trials, those patients who were taking Generic Armodafinil were awake for 28 hours, keeping the attention and performance. According to the media, the drug is widely used in the armies of the US and the UK for correction of the performance, especially by pilots. The medication has virtually no effect on physical performance; it reduces the need for sleep. The only indications for its appointment in clinical medicine were cases of narcolepsy disease. It can also be effectively used to enhance the concentration. Indian pharmaceutical company

Lupin has recently announced that its subdivision Lupin Pharmaceuticals received conditional approval of the Office of quality control products and Drug Administration of the US for the product Armodafinil at a dose of 50 mg, 100mg, 150mg, 200mg and 250mg in addition to capsules of Doxycycline at a dose of 40 mg (30 mg of immediate-release drug and 10mg of delayed release one).

The drug is a generics version of the drug Nuvigil of the company Cephalon, which is produced at a dose of 50mg, 100mg, 200mg and 250mg and is intended for the treatment of insomnia by adult patients with excessive sleepiness that is associated with obstructive sleep apnea syndrome, narcolepsy, or sleep disorders associated with shift work. According to the market research of the firm IMS Health, the sale of the drug Nuvigil in the US at doses of 50 mg, 150 mg, 200 mg and 250 mg were approximately 420 million US dollars for 12 months for the period of March 2013.

The drug doxycycline of Lupin company is a generic drug of oracea in capsules of Galderma Laboratories at a dose of 40 mg and it is intended to treat inflammation of the skin (pimples and nodules) associated with rosacea by adult patients. Annual sales of the drug Oracea in the US reached 319 million US dollars for 12 months for the period of March 2013, according to IMS Health. Nowadays you can buy Armodafinil at any drugstore of the US or order Armodafinil online.